Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology-Reference-Cited by-同舟云学术

Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology

Published:2018-01-08 Issue:5 Volume:121 Page:703-715
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Poon Darren Ming-Chun¹,Chan Chi-Kwok²,Chan Tim-Wai³,Cheung Foon-Yiu⁴,Kwong Philip Wai-Kay⁵,Lee Eric Ka-Chai⁶,Leung Angus Kwong-Chuen⁷,Leung Simon Yiu-Lam⁸,Ma Wai-Kit⁹^ORCID,So Hing-Shing¹⁰,Tam Po-Chor⁹,Ho Lap-Yin¹¹

Affiliation:

1. Department of Clinical Oncology; State Key Laboratory in Oncology in South China; Sir YK Pao Centre for Cancer; Hong Kong Cancer Institute and Prince of Wales Hospital; Chinese University of Hong Kong; Hong Kong Hong Kong

2. Department of Surgery; Prince of Wales Hospital; Hong Kong Hong Kong

3. Department of Clinical Oncology; Queen Elizabeth Hospital; Hong Kong Hong Kong

4. Hong Kong Integrated Oncology Centre; Hong Kong Hong Kong

5. Department of Clinical Oncology; Queen Mary Hospital; Hong Kong Hong Kong

6. Department of Clinical Oncology; Tuen Mun Hospital; Hong Kong Hong Kong

7. Radiotherapy& Oncology Centre; Hong Kong Baptist Hospital; Hong Kong Hong Kong

8. Central Urology Clinic; Hong Kong Hong Kong

9. Department of Surgery; Queen Mary Hospital; Hong Kong Hong Kong

10. Division of Urology; Department of Surgery; United Christian Hospital; Hong Kong Hong Kong

11. Asia Clinic; Hong Kong Hong Kong

Funder

HKUA